0.0745
+0.0235
+(46.08%)
At close: January 29 at 8:10:46 AM GMT+1
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 3 | 1 | 3 | 3 |
| Avg. Estimate | 7.72M | 792k | 24.91M | 4.29M |
| Low Estimate | 5.6M | 792k | 22.8M | 2.26M |
| High Estimate | 10.63M | 792k | 27.83M | 6.8M |
| Year Ago Sales | 4.8M | 6.86M | 4.8M | 24.91M |
| Sales Growth (year/est) | 60.80% | -88.45% | 419.01% | -82.76% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| YP2A.F | -- | -- | -- | -- |
| S&P 500 | 9.91% | 10.33% | 14.01% | 13.75% |
Upgrades & Downgrades
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/25/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/3/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/29/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/17/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/26/2024 |
Related Tickers
2UV.DU Applied Therapeutics Inc
0.5630
-2.00%
M55.F MacroGenics, Inc.
2.8800
-0.48%
3G0.BE Altimmune Inc
6.43
-4.20%
0M4.DU Mersana Therapeutics Inc
0.5988
+1.39%
2UV.F Applied Therapeutics, Inc.
0.5710
+10.87%
1VT.DU Viking Therapeutics Inc
32.32
+0.53%
AT20.F Atara Biotherapeutics, Inc.
8.30
+11.41%
8AW0.BE Ocean Biomedical Inc
0.1930
+6.63%
NV4.F Cellectar Biosciences, Inc.
0.2160
+8.00%
8AW0.F Ocean Biomedical, Inc.
0.1940
-11.82%